vaccine
-
BiondVax’s universal flu vaccine improves existing flu vaccines in elderly
BiondVax Pharmaceuticals announced positive results from its second Phase II clinical trial (BVX-005) of the Universal Influenza Vaccine (Multimeric-001) developed by Biondvax for improving existing flu vaccines in elderly.
vaccine | 20 February 2012
-
Sanofi Pasteur acquires exclusive, worldwide license for acne vaccine and treatment
Pre-clinical vaccine was developed by researchers at the University of California, San Diego.
vaccine | 21 September 2011
-
Sanofi Pasteur donates vaccine strain used for polio eradication to WHO
Vaccine strain used in the production of oral polio vaccines against type 3 poliovirus.
vaccine | 20 September 2011
-
iBio announces malaria vaccine milestone achievement
iBio Inc announced successful animal testing of a malaria vaccine candidate produced using its proprietary iBioLaunch platform and sponsored by the Bill & Melinda Gates Foundation. Results were published in the August issue of the peer-reviewed, scie…
vaccine | 05 August 2011
-
IVI and Inviragen announce collaboration to accelerate development of dengue vaccine
The International Vaccine Institute (IVI) and Inviragen Inc announced the signing of a memorandum of understanding with the ultimate objective of making a dengue vaccine widely accessible to people in countries where this disease is endemic. The IVI,…
vaccine | 04 August 2011
-
Merck, Serum Institute to develop and expand access to pneumococcal conjugate vaccine
Merck and Serum Institute of India Limited announced an agreement to work together to develop and commercialize a pneumococcal conjugate vaccine (PCV) for use in the emerging and developing world countries. It is estimated that one out of every two c…
vaccine | 04 August 2011
-
VaxOnco to sponsor phase 1 trial of breast/ovarian cancer therapeutic vaccine
VaxOnco announced that following FDA IND approval, it will sponsor a phase 1 folate receptor alpha-targeted therapeutic vaccine clinical trial in disease-free patients, previously diagnosed with either breast or ovarian cancer at Mayo Clinic. The …
vaccine | 26 July 2011
-
VaxyGen Vaccines announces strategic collaboration with The Serum Institute of India
VaxyGen Vaccines Ltd announced the signing of a strategic collaboration agreement with the Serum Institute of India (SII). Under the terms of the agreement, VaxyGen Vaccines Ltd will have exclusive rights to commercialize certain SII approved and pip…
vaccine | 29 June 2011
-
Sanofi Pasteur’s typhoid vaccine granted prequalification by WHO
Designation will facilitate global access to vaccine for the prevention of typhoid fever in the most vulnerable populations around the world.
vaccine | 23 June 2011
-
Inviragen initiates phase 1 study of HFMD vaccine in Singapore
Inviragen announced the initiation of the first clinical trial of the company’s proprietary hand, foot and mouth disease (HFMD) investigational vaccine, INV21. This is a highly purified virus particle preparation designed to protect against HFMD ca…
vaccine | 17 June 2011
